Ingredients Sun protection Avobenzone
98Bm
Tier · Moderate evidence
Sun protection

Avobenzone

INCI: Butyl Methoxydibenzoylmethane · Also called: Butyl Methoxydibenzoylmethane, Parsol 1789, BMDBM, Eusolex 9020

The most widely used chemical UVA filter in Western sunscreens, critical for blocking the longer wavelengths that drive photoaging, pigmentation, and deeper DNA damage. Always look for it paired with a photostabiliser such as octocrylene so it doesn't degrade and leave you unprotected mid-day.

For your skin

The most widely used chemical UVA filter in Western sunscreens, critical for blocking the longer wavelengths that drive photoaging, pigmentation, and deeper DNA damage. Always look for it paired with a photostabiliser such as octocrylene so it doesn't degrade and leave you unprotected mid-day.

Want the science? Keep reading ↓

Mechanism of action

Avobenzone (butyl methoxydibenzoylmethane) absorbs UVA radiation (320–400 nm) via enol-to-keto tautomerism, converting UV photon energy to heat. It provides no meaningful UVB coverage — separate UVB filters are required for broad-spectrum protection. Critically, avobenzone is photounstable: extended UV exposure degrades the molecule and sharply reduces UVA protection unless the formula includes a photostabiliser (typically octocrylene, bemotrizinol, or an antioxidant blend). FDA-approved at up to 3% in OTC sunscreens.

Why we tier this moderate

2 cited papers across 2 countries. The mechanism is well-described and there's at least one controlled trial in the literature, but we tier this Moderate rather than Strong to stay honest about how many specific papers we cite directly.

1
European Union
1
United States

Cited research

🇪🇺

Afonso S, Horita K, Sousa e Silva JP, et al. Photodegradation of avobenzone: stabilization effect of antioxidants. J Photochem Photobiol B. 2014;140:36-40.

2014Mechanism onlyPMID:25086322View source ↗
🇺🇸

Wang SQ, Stanfield JW, Osterwalder U. In vitro assessments of UVA protection by popular sunscreens available in the United States. J Am Acad Dermatol. 2008;59(6):934-42.

2008Positive — efficacyPMID:18835064View source ↗

Sources: PubMed · KCI · J-Stage · CNKI · Wanfang · SFD · MFDS · Cochrane · SCCS · CIR. Every entry points to a specific document. See methodology for what each outcome label means.